Clinical Trial Update: Lexapro®'s Efficacy After Dose Escalation in Remission Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy of Lexapro after dose escalation in remission for Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED